Minocycline for schizophrenia: a brief overview
The tetracyclic antibiotic minocycline appears to have positive results when added to the the treatment prescribed for persistent symptoms of schizophrenia. To provide an overview of the literature on minocycline and schizophrenia. PubMed, up to September 2013, was scanned for articles relating to m...
Gespeichert in:
| Veröffentlicht in: | Tijdschrift voor psychiatrie 2014, Vol.56 (6), p.402-406 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | dut |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 406 |
|---|---|
| container_issue | 6 |
| container_start_page | 402 |
| container_title | Tijdschrift voor psychiatrie |
| container_volume | 56 |
| creator | Hovens, J E Onderwater, T A M |
| description | The tetracyclic antibiotic minocycline appears to have positive results when added to the the treatment prescribed for persistent symptoms of schizophrenia.
To provide an overview of the literature on minocycline and schizophrenia.
PubMed, up to September 2013, was scanned for articles relating to minocycline and schizophrenia.
We found seven case reports with regard to the use of minocycline as an additive in the treatment of persistent schizophrenia. Furthermore, an open-label study and two randomised placebo-controlled studies regarding this addition were published. Using minocycline may add to the improvement of negative symptoms and cognition in patients with schizophrenia.
It is concluded, albeit somewhat cautiously, that minocycline may be helpful in treating negative and cognitive symptoms in schizophrenia. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1539712882</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1539712882</sourcerecordid><originalsourceid>FETCH-LOGICAL-p564-3732ac36e125af67e810a0daa96043325d21e50904c8a854c81688faa666fe833</originalsourceid><addsrcrecordid>eNo1j71OwzAURj2AaCm8AsrIEmH72o7Nhir-pCKW7tGtc60apXGwSVF5eipRlvMtR590zticA4e6AXAzdlnKB-fKOGgu2Ewqp0ELNWd3b3FI_uD7OFAVUq6K38afNG4zDRHvK6w2OVKo0p7yPtL3FTsP2Be6Pu2CrZ8e18uXevX-_Lp8WNWjNqqGBiR6MCSkxmAasoIj7xCd4QpA6k4K0txx5S1afaQw1gZEY0wgC7Bgt3-3Y06fE5WvdheLp77HgdJUWqHBNUJaK4_qzUmdNjvq2jHHHeZD-98Iv1bHSpg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1539712882</pqid></control><display><type>article</type><title>Minocycline for schizophrenia: a brief overview</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Hovens, J E ; Onderwater, T A M</creator><creatorcontrib>Hovens, J E ; Onderwater, T A M</creatorcontrib><description>The tetracyclic antibiotic minocycline appears to have positive results when added to the the treatment prescribed for persistent symptoms of schizophrenia.
To provide an overview of the literature on minocycline and schizophrenia.
PubMed, up to September 2013, was scanned for articles relating to minocycline and schizophrenia.
We found seven case reports with regard to the use of minocycline as an additive in the treatment of persistent schizophrenia. Furthermore, an open-label study and two randomised placebo-controlled studies regarding this addition were published. Using minocycline may add to the improvement of negative symptoms and cognition in patients with schizophrenia.
It is concluded, albeit somewhat cautiously, that minocycline may be helpful in treating negative and cognitive symptoms in schizophrenia.</description><identifier>ISSN: 0303-7339</identifier><identifier>PMID: 24953514</identifier><language>dut</language><publisher>Netherlands</publisher><subject>Antipsychotic Agents - therapeutic use ; Cognition - drug effects ; Humans ; Minocycline - therapeutic use ; Schizophrenia - drug therapy ; Schizophrenic Psychology</subject><ispartof>Tijdschrift voor psychiatrie, 2014, Vol.56 (6), p.402-406</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4009</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24953514$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hovens, J E</creatorcontrib><creatorcontrib>Onderwater, T A M</creatorcontrib><title>Minocycline for schizophrenia: a brief overview</title><title>Tijdschrift voor psychiatrie</title><addtitle>Tijdschr Psychiatr</addtitle><description>The tetracyclic antibiotic minocycline appears to have positive results when added to the the treatment prescribed for persistent symptoms of schizophrenia.
To provide an overview of the literature on minocycline and schizophrenia.
PubMed, up to September 2013, was scanned for articles relating to minocycline and schizophrenia.
We found seven case reports with regard to the use of minocycline as an additive in the treatment of persistent schizophrenia. Furthermore, an open-label study and two randomised placebo-controlled studies regarding this addition were published. Using minocycline may add to the improvement of negative symptoms and cognition in patients with schizophrenia.
It is concluded, albeit somewhat cautiously, that minocycline may be helpful in treating negative and cognitive symptoms in schizophrenia.</description><subject>Antipsychotic Agents - therapeutic use</subject><subject>Cognition - drug effects</subject><subject>Humans</subject><subject>Minocycline - therapeutic use</subject><subject>Schizophrenia - drug therapy</subject><subject>Schizophrenic Psychology</subject><issn>0303-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j71OwzAURj2AaCm8AsrIEmH72o7Nhir-pCKW7tGtc60apXGwSVF5eipRlvMtR590zticA4e6AXAzdlnKB-fKOGgu2Ewqp0ELNWd3b3FI_uD7OFAVUq6K38afNG4zDRHvK6w2OVKo0p7yPtL3FTsP2Be6Pu2CrZ8e18uXevX-_Lp8WNWjNqqGBiR6MCSkxmAasoIj7xCd4QpA6k4K0txx5S1afaQw1gZEY0wgC7Bgt3-3Y06fE5WvdheLp77HgdJUWqHBNUJaK4_qzUmdNjvq2jHHHeZD-98Iv1bHSpg</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Hovens, J E</creator><creator>Onderwater, T A M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>2014</creationdate><title>Minocycline for schizophrenia: a brief overview</title><author>Hovens, J E ; Onderwater, T A M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p564-3732ac36e125af67e810a0daa96043325d21e50904c8a854c81688faa666fe833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>dut</language><creationdate>2014</creationdate><topic>Antipsychotic Agents - therapeutic use</topic><topic>Cognition - drug effects</topic><topic>Humans</topic><topic>Minocycline - therapeutic use</topic><topic>Schizophrenia - drug therapy</topic><topic>Schizophrenic Psychology</topic><toplevel>online_resources</toplevel><creatorcontrib>Hovens, J E</creatorcontrib><creatorcontrib>Onderwater, T A M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Tijdschrift voor psychiatrie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hovens, J E</au><au>Onderwater, T A M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Minocycline for schizophrenia: a brief overview</atitle><jtitle>Tijdschrift voor psychiatrie</jtitle><addtitle>Tijdschr Psychiatr</addtitle><date>2014</date><risdate>2014</risdate><volume>56</volume><issue>6</issue><spage>402</spage><epage>406</epage><pages>402-406</pages><issn>0303-7339</issn><abstract>The tetracyclic antibiotic minocycline appears to have positive results when added to the the treatment prescribed for persistent symptoms of schizophrenia.
To provide an overview of the literature on minocycline and schizophrenia.
PubMed, up to September 2013, was scanned for articles relating to minocycline and schizophrenia.
We found seven case reports with regard to the use of minocycline as an additive in the treatment of persistent schizophrenia. Furthermore, an open-label study and two randomised placebo-controlled studies regarding this addition were published. Using minocycline may add to the improvement of negative symptoms and cognition in patients with schizophrenia.
It is concluded, albeit somewhat cautiously, that minocycline may be helpful in treating negative and cognitive symptoms in schizophrenia.</abstract><cop>Netherlands</cop><pmid>24953514</pmid><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0303-7339 |
| ispartof | Tijdschrift voor psychiatrie, 2014, Vol.56 (6), p.402-406 |
| issn | 0303-7339 |
| language | dut |
| recordid | cdi_proquest_miscellaneous_1539712882 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Antipsychotic Agents - therapeutic use Cognition - drug effects Humans Minocycline - therapeutic use Schizophrenia - drug therapy Schizophrenic Psychology |
| title | Minocycline for schizophrenia: a brief overview |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T04%3A39%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Minocycline%20for%20schizophrenia:%20a%20brief%20overview&rft.jtitle=Tijdschrift%20voor%20psychiatrie&rft.au=Hovens,%20J%20E&rft.date=2014&rft.volume=56&rft.issue=6&rft.spage=402&rft.epage=406&rft.pages=402-406&rft.issn=0303-7339&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1539712882%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1539712882&rft_id=info:pmid/24953514&rfr_iscdi=true |